Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IBIO Top Institutional Holders
Holder Shares Date Reported % Out Value
Blackrock Inc. 11,575,051 Dec 30, 2020 5.36% 12,153,803
Vanguard Group, Inc. (The) 3,698,318 Dec 30, 2020 1.71% 3,883,233
Geode Capital Management, LLC 2,470,760 Dec 30, 2020 1.14% 2,594,298
State Street Corporation 2,110,575 Dec 30, 2020 0.98% 2,216,103
Northern Trust Corporation 1,954,299 Dec 30, 2020 0.90% 2,052,013
Susquehanna International Group, LLP 1,069,190 Dec 30, 2020 0.49% 1,122,649
Principal Financial Group, Inc. 1,023,325 Dec 30, 2020 0.47% 1,074,491
Nuveen Asset Management 542,852 Dec 30, 2020 0.25% 569,994
JP Morgan Chase & Company 498,147 Dec 30, 2020 0.23% 523,054
Charles Schwab Investment Management, Inc. 449,604 Dec 30, 2020 0.21% 472,084
https://finance.yahoo.com/quote/IBIO/holders?p=IBIO
$IDEX Real Estate Reimagined
Timios seamlessly provides an unparalleled real estate transaction experience, making every step simple to manage and stress-free. https://ideanomics.com/
$IDEX Accelerating Commercial EV Adoption in China
MEG competes in China using its Sales-to-Financing-to-Charging model (S2F2C), helping commercial fleet operators find the best vehicle for their needs and delivering solutions with innovative financing and charging technologies. https://ideanomics.com/
Hope some of you got in $ALTD.....living up to the Boards name. And again like my other play $UDHI got started without an IHUB following. Look at the Board....not many people on it yet still stock advancing. Hope you all had a GREAT trading day.
$KNDI Kandi K23 pure electric car
$IDEX Ideanomics Acquired A Land; Co Plans To Build An Assembly Line To Support Export Operations
Watch $BLLB next 2 weeks
Should flip grey to pink and run hard to .01, then when RM is announced, multi-pennies
$MJNA First to Deliver Prescription CBD Products to Epilepsy, Alzheimer’s Disease, Parkinson’s Disease, Chronic Pain, and Migraine Sufferers
HempMeds® Brasil, a subsidiary of Medical Marijuana, Inc., became the first company to have a cannabis product, Real Scientific Hemp Oil™(RSHO™), prescribed for a number of indications when it was exported to Brazil for all forms of epilepsy, Alzheimer’s disease, Parkinson’s disease, chronic pain and migraines. https://www.medicalmarijuanainc.com/company-of-firsts/the-first-to-deliver-prescription-cbd-products-to-epilepsy-alzheimers-parkinsons-chronic-pain-migraines/
$BLLB is a grey to pink situation, with RM. I expect a run beyond .01 in the near future. Current pink status is coming in days IMO.
Beautiful pick Bud, drop us a line on the weekend board if you can!
https://investorshub.advfn.com/Weekend-Warriors-27071/
$HEMP SMART MONEY ACCUMULATING DOWN HERE! HEMP
Loading Zone $CVSI
$MJNA Parsing Through CBD, Focus on Revenue $$$ Bullish
$INKW on alert ~ Companies of all types, from private to public, from OTC to NYSE, have seen huge gains because of the passage of the 2018 Farm Bill. Some prominent examples include:
Expansion via acquisitions like Greene Concepts, Inc. (OTC: INKW) and their recent acquisition of Mammoth Ventures, Inc. a ready-to-drink beverage products company with bottling facility and more.
New Facilities, New Acquisitions, New Exchange Listings and Worldwide Expansion: Snapshot of the Cannabis Market
Date: 05/08/2019 @ 8:40AM
https://ih.advfn.com/stock-market/USOTC/greene-concepts-inc-INKW/stock-news/79862183/new-facilities-new-acquisitions-new-exchange-lis
Greene Concepts, Inc. (greeneconcepts.com) is a publicly traded company. Through its recently acquired wholly-owned subsidiary, Mammoth Ventures Inc., the Company has entered into the specialty beverage and bottling business.
http://greeneconcepts.com/
$NIO NIO said to launch supercharger stations in April NIO
http://autonews.gasgoo.com/70015796.html
$PMCB Global Pancreatic cancer Market Survey Size, Share, Insight Details 2016 Set to Grow according to Forecasts 2022
Posted: Oct 11, 2016 4:16 AM PDT
Updated: Oct 11, 2016 4:16 AM PDT
Global Pancreatic cancer Information, by type (endocrine pancreas cancer, exocrine pancreas cancer and others), by treatment type (surgery, chemotherapy, radiation therapy and others), by end users (hospital, clinics, research institutes and others) – Forecast to 2022
Pune, India – October 11, 2016 /MarketersMedia/ —
Intended Audience:
• Companies into Pancreatic cancer
• Research and Development (R&D) Companies
• Independent Research Laboratories
• Market Research and Consulting Service Providers
• Medical Research Laboratories
Key Players for Pancreatic cancer market:
• PharmaCyte Biotech Inc. (US)
• OncoGenex Pharmaceuticals Inc.
• Oncolytics Biotech (Canada)
• DiffusionPharmaceuticals (US)
• Polaris Pharmaceuticals, Inc.
• Sun BioPharma, Inc.
• Midatech Pharma PLC (UK)
Get Sample for this Report @ https://www.marketresearchfuture.com/sample-request/global-pancreatic-cancer-market-research-report-forecast-to-2022
Segments:
Global Pancreatic cancer market has been segmented on the basis of type which comprise of endocrine pancreas cancer, exocrine pancreas cancer and others. On the basis of treatment type; market is segmented into; surgery, radiation therapy, chemotherapy and others. On the basis of end users; market is segmented as; hospital, clinics, research institutes and others.
Study Objectives of Pancreatic cancer Market:
• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Pancreatic cancer market
• To provide insights about factors affecting the market growth
• To analyze the pancreatic cancer market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by type, by treatment type, by end users and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global pancreatic cancer market.
Market Synopsis of Pancreatic cancer market:
Taste the market data and market information presented through more than 50 market data tables and figures spread in 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Retinal Detachment treatment Market Research Report- Forecast To 2022“
Market Scenario:
Cancer starts when cells in the body begin to grow out of control. Pancreatic cancer starts when cells in the pancreas start to grow uncontrollably. It causes Symptoms like abdominal pain, weight loss, diarrhea, and jaundice. The tumor hinders the normal functioning of pancreas. The biggest risk factor for developing pancreatic cancer is smoking. To diagnose the cancer doctor will do a complete physical exam and history check and then blood, urine, and stool tests may be done.
Market for Pancreatic cancer is growing as there is an increase in the consumption of alcohol, smoking and change is lifestyle. The global market for Pancreatic cancer is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%.
Regional Analysis of Pancreatic cancer Market:
Globally North America is the largest market for pancreatic cancer. The North American market for Pancreatic cancer is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. The prevalence of pancreatic cancer is more in North American countries.
Europe is expected to be the second-largest market for pancreatic cancer which is expected to grow at a CAGR of XX%. Asia-Pacific is anticipated to be the fastest growing region across the globe, and is expected to grow at a CAGR of XX% during the forecasted period.
Access Report Details @ https://www.marketresearchfuture.com/reports/global-pancreatic-cancer-market-research-report-forecast-to-2022
Global Pancreatic Cancer by Region
North America
• US
• Canada
Europe
• Western Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Western Europe
• Eastern Europe
Asia
• China
• India
• Japan
• South Korea
• Rest of Asia
Pacific
Latin America, Middle East & Africa
The report for Global Pancreatic cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Related Reports:
Global Thymus Cancer Market Research Report- Forecast To 2024
Thymus cancer is a tumor formed on the outer surface originating from the epithelial cells of the thymus. Thymus is a small organ located in the upper chest under the breast bone and makes specific type of white blood cells which help the body fight infection. There are no prominent causes or risk factors for thymus cancer. Thymus cancer is an uncommon tumor, best known for its association with the neuromuscular disorder myasthenia gravis and is found in 20% of patients with myasthenia gravis. It is a rare type of cancer which accounts for only 1 % of total cancers.
Know More about Report @ https://www.marketresearchfuture.com/reports/global-thymus-cancer-market-research-report-forecast-to-2024
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
For more information, please visit https://www.marketresearchfuture.com
Contact Info:
Name: Ruwin Mendez
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Hadapsar Pune, India – 411028
Phone: +1 (339) 368 6938
Source: http://marketersmedia.com/global-pancreatic-cancer-market-survey-size-share-insight-details-2016-set-to-grow-according-to-forecasts-2022/137496
Release ID: 137496
This article was originally distributed via SproutNews. SproutNews, Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com
$PMCB Extraction Technology Becoming Paramount in Cannabis Industry as Consumers Gravitate Towards Concentrates and Higher Quality of Substance
http://www.prnewswire.co.uk/news-releases/extraction-technology-becoming-paramount-in-cannabis-industry-as-consumers-gravitate-towards-concentrates-and-higher-quality-of-substance-587443771.html
$PMCB All Latest News
OTC Disclosure & News Service
Sep 1, 2016 PharmaCyte Biotech Reports on Progress in Its Medical Cannabis Program Press Release
Aug 2, 2016 Dr. Mark L. Rabe Presents PharmaCyte Biotech’s Ongoing Research at Cannabis Cancer Forum Press Release
Jul 29, 2016 PharmaCyte Biotech Releases Shareholder Call Playback Information Press Release
Jul 25, 2016 PharmaCyte Biotech Shareholder Call Update Press Release
Jul 19, 2016 As Diabetes Becomes Global Epidemic, PharmaCyte Biotech's Insulin Producing Cells Receive 20 Years of Protection Press Release
Jul 14, 2016 PharmaCyte Biotech Receives Patent Protection of the Melligen Cells to Treat Diabetes Press Release
Jul 11, 2016 PharmaCyte Biotech to Hold Shareholder Call Press Release
Jul 7, 2016 PharmaCyte Biotech Uses "Artificial Liver" to Treat Advanced Pancreatic Cancer Press Release
Jul 5, 2016 PharmaCyte’s Research on Medical Uses of Cannabinoids Supported by Recent Scientific Article Press Release
Jun 28, 2016 PharmaCyte Biotech CEO Interviewed by Small Cap Nation
$GNPT, $MEDT, $SDVI, COBI, $VGID, $SURE, $LUSI: The next $.00x stock!
ALERT: TRON update to OTC
Filings are next, we just noticed this added:
Business Description
Toron, Inc. (hereinafter 'Toron' or the 'Company') is an innovative disruptive healthcare technology company headquartered in Miami Beach, Florida. The company is focused on integrating access to electronic data interfaces for healthcare providers and payer systems in a user-friendly manner. Toron provides ease of use for patients by simplifying their check-in registration process. Simplifying this process also reduces healthcare providers' administrative expenses and lost revenue due to insurance rejections or denials.
Thanks for the inspiration, good master Bunny!
$$$ TRON @ .003, Target .03
>>>>TRON<<<<
>>>>AHIX<<<<
>>>>CIRC<<<<
OM fugnnn G! not a gamble on an otc pinky turd stock!!! i'd never do such a thing! LMAO says the guy who's best investment is a company with 5 BILLION on the A/S LMAO.
IT's A GAMBLE A SPECULATIVE BET but i think somebody wants those shares, they act like it in my opinion of speculations......
ANY COMPENSATION DUE TO BEACON?
Stock still trading 4 years latter!!!!! :)
now i'm gettin' you. you not just a wascally wabbit, you a smart bunny. brain cell just got off break. LOL
That link is 2012! Bwaaaaa flmao lol.....
I wonder if 2 reverse splits squeezed out investors?
ok...i think i finally got to the page. i saw the word leasing. LOL and beacon redevelopment. and lawsuit. it's a lot of info for 1 brain cell to handle. LMAO
Must have been worth DOMINION breaking locks and going to court for
Must have been big enough for DOMINION to use it!
LMAO LOL.... That's NIGHT'S sandwich pride and baby......
DO you think DOMINION wants to use that same well on BEACON property that they used in the past? HAVE THEY MADE ANY UPGRADES, COMPROMISES, Or STUFF STUFF?
i'm just getting a bunch of generic information about shale gas formations. lol
70k over 40 years...compounded interest and adjusted for inflation, i'd say a lot...LOL
Followers
|
52
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2083
|
Created
|
08/23/13
|
Type
|
Free
|
Moderator TenTimesPay | |||
Assistants |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |